Laromustine: The return of alkylators to non-myeloablative therapy of AML

Francis J. Giles*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1022-1023
Number of pages2
JournalLeukemia Research
Issue number8
StatePublished - Aug 2009


  • AML
  • ATG
  • Alkylating agents
  • Anthracyclines
  • Cloretazine
  • Cytarabine
  • Elderly
  • Laromustine
  • VNP40101M

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this